{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:01:12Z","timestamp":1782928872005,"version":"3.54.5"},"reference-count":30,"publisher":"Royal Society of Chemistry (RSC)","issue":"19","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":234,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD025223-01A1"],"award-info":[{"award-number":["1S10OD025223-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI69686"],"award-info":[{"award-number":["R01AI69686"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI089621"],"award-info":[{"award-number":["T32AI089621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008639","name":"A. James Clark School of Engineering","doi-asserted-by":"publisher","award":["Clark Doctoral Fellowship"],"award-info":[{"award-number":["Clark Doctoral Fellowship"]}],"id":[{"id":"10.13039\/100008639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","award":["3-SRA-2023-1309-S-B"],"award-info":[{"award-number":["3-SRA-2023-1309-S-B"]}],"id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2BX005756"],"award-info":[{"award-number":["IK2BX005756"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":["Biomater. Sci."],"abstract":"<jats:p>Microparticles are loaded with peptides in distinct configurations, which result in comparable immune cell activity and enable flexible CMC development.<\/jats:p>","DOI":"10.1039\/d5bm00328h","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T19:41:15Z","timestamp":1755978075000},"page":"5538-5549","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulation of response to antigen peptides is independent of peptide distribution in lymph node therapeutics"],"prefix":"10.1039","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-1350","authenticated-orcid":false,"given":"Ryan A.","family":"McIlvaine","sequence":"first","affiliation":[{"name":"Fischell Department of Bioengineering, University of Maryland, College Park, 8278 Paint Branch Drive, College Park, MD 20742, USA"},{"name":"Robert E. Fischell Institute for Biomedical Devices, 8278 Paint Branch Drive, College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-7053","authenticated-orcid":false,"given":"Senta M.","family":"Kapnick","sequence":"additional","affiliation":[{"name":"Robert E. Fischell Institute for Biomedical Devices, 8278 Paint Branch Drive, College Park, MD 20742, USA"},{"name":"Department of Veterans Affairs, VA Maryland Health Care System, 10. N Green Street, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-0300","authenticated-orcid":false,"given":"Sean T.","family":"Carey","sequence":"additional","affiliation":[{"name":"Fischell Department of Bioengineering, University of Maryland, College Park, 8278 Paint Branch Drive, College Park, MD 20742, USA"},{"name":"Robert E. Fischell Institute for Biomedical Devices, 8278 Paint Branch Drive, College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6668-6928","authenticated-orcid":false,"given":"Christopher M.","family":"Jewell","sequence":"additional","affiliation":[{"name":"Robert E. Fischell Institute for Biomedical Devices, 8278 Paint Branch Drive, College Park, MD 20742, USA"},{"name":"Department of Veterans Affairs, VA Maryland Health Care System, 10. N Green Street, Baltimore, MD 21201, USA"},{"name":"Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, MD, 21201, USA"},{"name":"Marlene and Stewart Greenebaum Cancer Center, 22 S. Greene Street, Suite N9E17, Baltimore, MD, 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"292","published-online":{"date-parts":[[2025]]},"reference":[{"key":"D5BM00328H\/cit1\/1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"D5BM00328H\/cit2\/1","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"Miller","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"D5BM00328H\/cit3\/1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2017.12.010","volume":"89","author":"Prasad","year":"2018","journal-title":"J. Autoimmun."},{"key":"D5BM00328H\/cit4\/1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.ymthe.2017.04.015","volume":"25","author":"Pearson","year":"2017","journal-title":"Mol. Ther."},{"key":"D5BM00328H\/cit5\/1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/21691401.2019.1699812","volume":"48","author":"Villalba","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"D5BM00328H\/cit6\/1","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00125-017-4419-8","volume":"60","author":"Xu","year":"2017","journal-title":"Diabetologia"},{"key":"D5BM00328H\/cit7\/1","doi-asserted-by":"crossref","first-page":"640935","DOI":"10.3389\/fimmu.2021.640935","volume":"12","author":"Lutterotti","year":"2021","journal-title":"Front. Immunol."},{"key":"D5BM00328H\/cit8\/1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2013.3022","volume":"70","author":"Walczak","year":"2013","journal-title":"JAMA Neurol."},{"key":"D5BM00328H\/cit9\/1","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1212\/WNL.0000000000005118","volume":"90","author":"Chataway","year":"2018","journal-title":"Neurology"},{"key":"D5BM00328H\/cit10\/1","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"D5BM00328H\/cit11\/1","doi-asserted-by":"crossref","first-page":"188ra75","DOI":"10.1126\/scitranslmed.3006168","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"D5BM00328H\/cit12\/1","volume-title":"Multicenter, Phase Ib\/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis - RED4MS Trial","author":"Cellerys AG","year":"2025","unstructured":"Cellerys AG ,  Multicenter, Phase Ib\/IIa Study on the Safety and Efficacy of Autologous Peptide-coupled Red Blood Cells in Patients with Relapsing Remitting Multiple Sclerosis - RED4MS Trial ,  clinicaltrials.gov ,  2025"},{"key":"D5BM00328H\/cit13\/1","volume-title":"Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS)","author":"Fundaci\u00f3 Institut Germans Trias i Pujol","year":"2023","unstructured":"Fundaci\u00f3 Institut Germans Trias i Pujol ,  Tolerance-Induction With Dendritic Cells Treated With Vitamin-D3 and Loaded With Myelin Peptides, in Multiple Sclerosis Patients (TOLERVIT-MS) ,  clinicaltrials.gov ,  2023"},{"key":"D5BM00328H\/cit14\/1","volume-title":"A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC","author":"Johnson & Johnson Enterprise Innovation Inc.","year":"2025","unstructured":"Johnson & Johnson Enterprise Innovation Inc. ,  A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC ,  clinicaltrials.gov ,  2025"},{"key":"D5BM00328H\/cit15\/1","volume-title":"Open Label, Phase II, Study: Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Patients With Stage III\/IV Untreated and Relapsed Follicular Lymphoma","author":"Kolstad","year":"2021","unstructured":"A.Kolstad ,  Open Label, Phase II, Study: Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Patients With Stage III\/IV Untreated and Relapsed Follicular Lymphoma ,  clinicaltrials.gov ,  2021"},{"key":"D5BM00328H\/cit16\/1","volume-title":"Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis: the TOLERANT Trial","author":"van Laar","year":"2022","unstructured":"J. M.van Laar ,  Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis: the TOLERANT Trial ,  clinicaltrials.gov ,  2022"},{"key":"D5BM00328H\/cit17\/1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41467-023-36225-5","volume":"14","author":"Gammon","year":"2023","journal-title":"Nat. Commun."},{"key":"D5BM00328H\/cit18\/1","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","volume":"16","author":"Tostanoski","year":"2016","journal-title":"Cell Rep."},{"key":"D5BM00328H\/cit19\/1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409563122","volume":"122","author":"Kapnick","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"D5BM00328H\/cit20\/1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/10717544.2021.1943056","volume":"28","author":"Hua","year":"2021","journal-title":"Drug Delivery"},{"key":"D5BM00328H\/cit21\/1","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1073\/pnas.1105200108","volume":"108","author":"Jewell","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"D5BM00328H\/cit22\/1","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1021\/acs.chemmater.4c00947","volume":"36","author":"Bridgeman","year":"2024","journal-title":"Chem. Mater."},{"key":"D5BM00328H\/cit23\/1","doi-asserted-by":"crossref","first-page":"2205105","DOI":"10.1002\/advs.202205105","volume":"10","author":"Carey","year":"2023","journal-title":"Adv. Sci."},{"key":"D5BM00328H\/cit24\/1","doi-asserted-by":"crossref","first-page":"115315","DOI":"10.1016\/j.addr.2024.115315","volume":"209","author":"Shah","year":"2024","journal-title":"Adv. Drug Delivery Rev."},{"key":"D5BM00328H\/cit25\/1","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsabm.3c00136","volume":"6","author":"Edwards","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"D5BM00328H\/cit26\/1","volume-title":"A Phase 1, Multicenter, Open-label Study of UB-VV111 in Combination With Rapamycin in Relapsed\/Refractory (R\/R) CD19+ B-cell Malignancies","author":"Umoja Biopharma","year":"2024","unstructured":"Umoja Biopharma ,  A Phase 1, Multicenter, Open-label Study of UB-VV111 in Combination With Rapamycin in Relapsed\/Refractory (R\/R) CD19+ B-cell Malignancies ,  clinicaltrials.gov ,  2024"},{"key":"D5BM00328H\/cit27\/1","doi-asserted-by":"crossref","first-page":"832010","DOI":"10.3389\/falgy.2022.832010","volume":"3","author":"Chabot","year":"2022","journal-title":"Front. Allergy"},{"key":"D5BM00328H\/cit30\/1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jconrel.2023.03.050","volume":"360","author":"Jiang","year":"2023","journal-title":"J. Controlled Release"},{"key":"D5BM00328H\/cit31\/1","doi-asserted-by":"crossref","first-page":"120807","DOI":"10.1016\/j.ijpharm.2021.120807","volume":"605","author":"Operti","year":"2021","journal-title":"Int. J. Pharm."},{"key":"D5BM00328H\/cit32\/1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/13816128113199990399","volume":"20","author":"Bohr","year":"2014","journal-title":"Curr. Pharm. Des."}],"container-title":["Biomaterials Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2025\/BM\/D5BM00328H","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:25:30Z","timestamp":1782926730000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.rsc.org\/bm\/article\/13\/19\/5538-5549\/881291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025,9,23]]}},"URL":"https:\/\/doi.org\/10.1039\/d5bm00328h","relation":{},"ISSN":["2047-4830","2047-4849"],"issn-type":[{"value":"2047-4830","type":"print"},{"value":"2047-4849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}